Recommendations for research

Recommendations for research

The guideline committee has made the following recommendations for research.

Key recommendations for research

1 Metabolic assessment

What is the clinical and cost effectiveness of full metabolic assessment compared with standard advice alone, in people with recurrent calcium oxalate stones?

To find out why the committee made the research recommendation on metabolic assessment, see rationale and impact.

2 Alpha blockers and ureteroscopy

What is the clinical and cost effectiveness of tamsulosin as an adjunct to ureteroscopy?

To find out why the committee made the research recommendation on alpha blockers and ureteroscopy, see rationale and impact.

3 Preventive treatment following shockwave lithotripsy

What is the clinical and cost effectiveness of empirical potassium citrate or bendroflumethiazide as preventive treatment for people with small residual fragments following shockwave lithotripsy for renal and ureteric stones?

To find out why the committee made the research recommendation on preventive treatment following shockwave lithotripsy, see rationale and impact.

4 Frequency of follow‑up imaging

What is the clinical and cost effectiveness of 6‑monthly imaging for 3 years for people with recurrent calcium renal or ureteric stones?

To find out why the committee made the research recommendation on frequency of follow‑up imaging, see rationale and impact.

5 Non-steroidal anti-inflammatory drugs (NSAIDs) – route of administration

What is the most clinically and cost effective route of administration for NSAIDs in the management of acute pain thought to be due to renal or ureteric stones?

To find out why the committee made the research recommendation on non-steroidal anti-inflammatory drugs – route of administration, see rationale and impact.

  • National Institute for Health and Care Excellence (NICE)